Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.1825

Bid

0.1753

Ask

0.1825

Volume

4,958

0.00 Day's Range 0.00

0.141 52 Week Range 21.56

Market Cap

1.719M

Previous Close

0.1757

Open

Last Trade

500

0.1825

(formt)

Last Trade Time

08:07:43

Financial Volume

VWAP

Average Volume (3m)

7,052,677

Shares Outstanding

9,420,489

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-1.85

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.18. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.141 to $ 21.56.

Aptevo Therapeutics currently has 9,420,489 shares outstanding. The market capitalization of Aptevo Therapeutics is $1.66 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0885	-32.6568265683	0.271	0.29	0.141	3557661	0.18614917	CS
4	-0.2065	-53.0848329049	0.389	0.389	0.141	2470387	0.27744159	CS
12	-0.143	-43.9324116743	0.3255	0.6559	0.141	7052677	0.52738887	CS
26	-4.4075	-96.0239651416	4.59	4.9979	0.141	3726350	0.59735328	CS
52	-13.9899	-98.7122858514	14.1724	21.56	0.141	2111766	1.68647969	CS
156	-733.7375	-99.9751335295	733.92	971.5156	0.141	1125244	195.50486658	CS
260	-30.6131	-99.4073828729	30.7956	2640	0.141	870335	272.46827617	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSSMaison Solutions Inc	$ 1.49 (108.39%)	8.95M
SEELSeelos Therapeutics Inc	$ 0.3345 (76.05%)	5.29M
TRNRInteractive Strength Inc	$ 0.3676 (55.56%)	39.07M
HSCSHeart Test Laboratories Inc	$ 4.30 (46.26%)	4.32M
GBNYGenerations Bancorp NY Inc	$ 15.38 (39.82%)	137.79k
BIVIBioVie Inc	$ 1.27 (-54.64%)	228.35k
GHSIGuardion Health Sciences Inc	$ 5.60 (-46.77%)	7.8k
TOIIWOncology Institute Inc	$ 0.014 (-25.13%)	23k
FRESFresh2 Group Ltd	$ 1.45 (-20.33%)	24.78k
LNWLight and Wonder Inc	$ 95.25 (-15.47%)	3.67k
MLGOMicroAlgo Inc	$ 0.2372 (19.56%)	39.85M
TRNRInteractive Strength Inc	$ 0.37 (56.58%)	39.13M
SLXNSilexion Therapeutics Corporation	$ 1.045 (35.68%)	10.62M
MSSMaison Solutions Inc	$ 1.49 (108.39%)	8.96M
SEELSeelos Therapeutics Inc	$ 0.3325 (75.00%)	5.36M